Stockreport

EU regulator backs Sanofi's injectable version of blood cancer drug [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Here are the details from the company's statement: * EMA's positive opinion for Sanofi's drug Sarclisa was onthe basis of late-stage trials ?which showed ?the subcuta [Read more]